Antonio Chistolini

Pubblicazioni

Titolo Pubblicato in Anno
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillations: the MAS study BLOOD ADVANCES 2024
Increased von Willebrand Factor Platelet-Binding Capacity Is Related to Poor Prognosis in COVID-19 Patients THROMBOSIS AND HAEMOSTASIS 2023
Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS 2023
Vaccine-induced immune thrombotic thrombocytopenia: a possible pathogenetic role of ChAdOx1 nCoV-19 vaccine encoded soluble SARS-CoV-2 spike protein HAEMATOLOGICA 2022
Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants: comparison between patients with major congenital thrombophilia versus non-thrombophilic patients INTERNAL AND EMERGENCY MEDICINE 2022
Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register INTERNAL AND EMERGENCY MEDICINE 2022
Thromboembolic events following mRNA vaccines for COVID 19: a case series JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2022
Immune thrombocytopenia during covid-19 pandemic: An italian monocentric experience EJHAEM 2022
Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry 213S2 (2022) S11–S42 2022
Diagnostica di laboratorio e strumentale Ematologia Smart, Edizioni Idelson Gnocchi 1908 2022
Complicanze in corso di emopatie ed emergenze emorragiche e trombotiche Ematologia Smart, Edizioni Idelson Gnocchi 1908 2022
Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study BIOMOLECULES 2022
SARS-CoV-2 infection predicts larger infarct volume in patients with acute ischemic stroke FRONTIERS IN CARDIOVASCULAR MEDICINE 2022
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2022
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients-30 months follow-up": Comment from Serrao et al JOURNAL OF THROMBOSIS AND HAEMOSTASIS 2022
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox? JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2021
Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going? JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2021
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox? JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2021
Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia NATURE COMMUNICATIONS 2021
Venous thromboembolism prophylaxis in plastic surgery: state of the art and our approach EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma